NOVO-B.CO vs. IXJ
Compare and contrast key facts about Novo Nordisk A/S (NOVO-B.CO) and iShares Global Healthcare ETF (IXJ).
IXJ is a passively managed fund by iShares that tracks the performance of the S&P Global Healthcare Sector Index. It was launched on Nov 13, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NOVO-B.CO or IXJ.
Correlation
The correlation between NOVO-B.CO and IXJ is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NOVO-B.CO vs. IXJ - Performance Comparison
Key characteristics
NOVO-B.CO:
-0.74
IXJ:
0.20
NOVO-B.CO:
-0.85
IXJ:
0.36
NOVO-B.CO:
0.88
IXJ:
1.04
NOVO-B.CO:
-0.63
IXJ:
0.15
NOVO-B.CO:
-1.37
IXJ:
0.35
NOVO-B.CO:
21.30%
IXJ:
6.38%
NOVO-B.CO:
39.78%
IXJ:
11.21%
NOVO-B.CO:
-64.64%
IXJ:
-40.60%
NOVO-B.CO:
-41.87%
IXJ:
-8.63%
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -4.63% return, which is significantly lower than IXJ's 6.85% return. Over the past 10 years, NOVO-B.CO has outperformed IXJ with an annualized return of 16.89%, while IXJ has yielded a comparatively lower 7.32% annualized return.
NOVO-B.CO
-4.63%
3.78%
-35.40%
-27.55%
24.51%
16.89%
IXJ
6.85%
3.50%
-7.05%
2.10%
6.93%
7.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NOVO-B.CO vs. IXJ — Risk-Adjusted Performance Rank
NOVO-B.CO
IXJ
NOVO-B.CO vs. IXJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and iShares Global Healthcare ETF (IXJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NOVO-B.CO vs. IXJ - Dividend Comparison
NOVO-B.CO's dividend yield for the trailing twelve months is around 1.66%, more than IXJ's 1.40% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | 1.66% | 1.59% | 1.01% | 2.09% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% | 1.73% |
IXJ iShares Global Healthcare ETF | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.47% | 1.73% | 2.85% | 1.38% |
Drawdowns
NOVO-B.CO vs. IXJ - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -64.64%, which is greater than IXJ's maximum drawdown of -40.60%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and IXJ. For additional features, visit the drawdowns tool.
Volatility
NOVO-B.CO vs. IXJ - Volatility Comparison
Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 11.84% compared to iShares Global Healthcare ETF (IXJ) at 3.80%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than IXJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.